4 November 2019 News
Sanofi has announced Toujeo (insulin glargine 300units/mL) is effective at reducing average blood sugar (HbA1c) in children and adolescents with type 1 diabetes, compared to insulin glargine 100units/mL (Gla-100).
21 October 2019 News
AstraZeneca has announced the US Food and Drug Administration (FDA) has approved Farxiga (dapagliflozin) to reduce the risk of hospitalisation for heart failure (hHF) in patients with type 2 diabetes...
14 October 2019 Analysis
Almost 15 years after the approval of the first GLP-1 agonist, the US FDA has approved the first oral version of this treatment approach for type 2 diabetes. What are...
8 October 2019 News
Pfizer and Ionis subsidiary Akcea have signed a global exclusive licensing agreement for antisense therapy AKCEA-ANGPTL3-LRx.
19 September 2019 Analysis
Pharmaceutical Technology lists the top tweeted terms on metabolic disorders in August 2019, based in data from GlobalData’s Influencer Platform.
11 September 2019 News
Lexicon Pharmaceuticals has announced a $260m settlement with Sanofi over the termination of their alliance, which focused on the development and commercialisation of diabetes drug Zynquista (sotagliflozin).
6 September 2019 News
Johnson & Johnson subsidiary Janssen has announced the European Commission (EC) has approved Stelara (ustekinumab) for patients with moderately to severely active ulcerative colitis (UC).
5 September 2019 Comment
Traffic to top type 2 diabetes websites tends to spike when major cardiovascular outcomes studies are presented
Visits to the Eli Lilly’s Trulicity (dulaglutide) brand site spiked massively in June 2019, bringing it to the top position by a landslide, despite a lack of digital display advertising...
28 August 2019 News
Pharmaceutical company Zogenix has signed a definitive agreement to buy Modis Therapeutics in a deal worth approximately $400m, including an upfront payment of $250m.
26 July 2019 News
Eli Lilly has secured the US Food and Drug Administration (FDA) approval for its Baqsimi nasal powder to be used as an emergency treatment for severe hypoglycaemia.